

          -  Any condition that, in the Investigator's opinion, will prevent adequate compliance
             with study therapy

          -  The following laboratory values at baseline (Day 0):

          -  Serum total bilirubin >=3 ULN

          -  Estimated glomerular filtration rate (eGFR) <=30 mL/min (based on serum creatinine)

          -  Known hypersensitivity to Camostat Mesilate

          -  Women who are pregnant or breastfeeding
      